Kerrisdale Advisers’s Novanta NOVT Stock Holding History

Kerrisdale Advisers’s Portfolio NOVT Stock Details NOVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,820	Closed	-$806K	–	127
2026 Q1	$806K	Buy	+6,820	New	+$895K	0.31%	70

Other funds holding NOVT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Kerrisdale Advisers's NOVT Position: Q2 2026 in Review

Kerrisdale Advisers sold out of Novanta (NOVT) in Q2 2026, closing a stake of 6,820 shares — an estimated $806K sold.

Kerrisdale Advisers first reported a position in NOVT in Q1 2026 and held it in 1 quarter. The position peaked at $806K in Q1 2026. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

Kerrisdale Advisers reported no remaining Novanta position as of Q2 2026 after selling out during the quarter.
Kerrisdale Advisers sold 6,820 Novanta shares in Q2 2026, an estimated $806K.
Kerrisdale Advisers first reported a position in Novanta in Q1 2026 and held it in 1 quarter.
Kerrisdale Advisers's Novanta position peaked at $806K in Q1 2026.
389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Kerrisdale Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.